AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Ocular TherapeutixTherapeuticsMDEvofem BiosciencesKamadaFlexion Therapeutics
SymbolNASDAQ:OCULNASDAQ:TXMDNASDAQ:EVFMNASDAQ:KMDANASDAQ:FLXN
Price Information
Current Price$7.07$1.14$4.66$7.55$12.18
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score2.01.51.61.42.4
Analysis Score2.63.43.53.54.6
Community Score3.02.62.72.23.0
Dividend Score0.00.00.00.00.0
Ownership Score4.01.01.00.04.0
Earnings & Valuation Score0.60.60.61.30.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$8.60$8.67$12.75$11.00$23.33
% Upside from Price Target21.64% upside660.23% upside173.61% upside45.70% upside91.57% upside
Trade Information
Market Cap$374.59 million$309.72 million$251.58 million$349.48 million$438.43 million
Beta1.652.110.331.252.06
Average Volume966,1884,585,275518,00689,633873,931
Sales & Book Value
Annual Revenue$4.23 million$49.65 millionN/A$127.19 million$72.96 million
Price / Sales89.196.24N/A2.646.44
CashflowN/AN/AN/A$0.58 per shareN/A
Price / CashN/AN/AN/A13.06N/A
Book Value($0.08) per share$0.03 per share$0.33 per share$3.04 per share($0.53) per share
Price / Book-88.3838.00N/A2.48-22.98
Profitability
Net Income$-86,370,000.00$-176,150,000.00$-80,030,000.00$22.25 million$-149,770,000.00
EPS($2.01)($0.68)($1.31)$0.55($3.93)
Trailing P/E RatioN/AN/AN/A13.98N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,430.64%-333.88%N/A16.87%-175.76%
Return on Equity (ROE)-6,659.51%-1,170.63%-304.11%16.24%-592.50%
Return on Assets (ROA)-106.33%-71.17%-169.44%13.19%-64.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio5.07%22.15%N/AN/A27.76%
Current Ratio4.96%3.44%0.95%6.55%5.08%
Quick Ratio4.86%3.20%0.95%4.91%4.52%
Ownership Information
Institutional Ownership Percentage53.46%67.09%75.06%12.91%83.08%
Insider Ownership Percentage7.70%13.76%9.40%N/A16.01%
Miscellaneous
Employees16134830408288
Shares Outstanding53.36 million271.68 million49.72 million44.52 million38.56 million
Next Earnings Date8/5/2020 (Estimated)8/4/2020 (Estimated)8/3/2020 (Estimated)8/4/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.